The serous, mucinous, and endometrioid tumor groups were considered in this investigation; the sensitivity, specificity, PPV, and NPV of HE4, CA125, ROMA, and CPH-I of different pathological subtype groups were shown in Table 5. The gene discussed is MUC16; the disease is endometrioid tumor.